Russell Angus C.
SEC-identified person · CIK 1534002 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Structure Therapeutics Inc. GPCR | Director | filed 2024 - 2026 |
| Lineage Cell Therapeutics, Inc. LCTX | Director | filed 2014 - 2025 |
| Revance Therapeutics, Inc. RVNC | Director | filed 2014 - 2025 |
| Therapeuticsmd, Inc. coff | Director | filed 2015 - 2022 |
| Mallinckrodt plc MNKTQ | Director | filed 2014 - 2022 |
| Intermune INC ITMN | Director | filed 2011 - 2014 |
| Questcor Pharmaceuticals INC QSC | Director | filed 2013 - 2014 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.